MMP2 and breast carcinoma: In breast cancer research Miao et al. [50] have found that the variant MMP2 genotype (-1306 CT or TT) was associated with substantially reduced risk of breast cancer [OR 0.46; 95% confidence interval (95% CI), 0.34–0.63], compared with the CC genotype.